GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,380.20+15.40 (+1.13%)
At close: 4:35PM GMT
| Previous close | 1,364.80 |
| Open | 1,367.40 |
| Bid | 1,380.20 x 0 |
| Ask | 1,380.60 x 0 |
| Day's range | 1,360.86 - 1,384.00 |
| 52-week range | 1,284.00 - 1,847.00 |
| Volume | 6,179,771 |
| Avg. volume | 10,471,368 |
| Market cap | 69.424B |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 10.93 |
| EPS (TTM) | 126.30 |
| Earnings date | 03 Feb 2021 |
| Forward dividend & yield | 0.76 (5.57%) |
| Ex-dividend date | 12 Nov 2020 |
| 1y target est | 1,644.50 |
- Fool.co.uk
Should I ignore the falling GlaxoSmithKline share price and pocket its 6% yield anyway?
The falling GlaxoSmithKline share price makes today's valuation look attractive, and the generous 5.86% yield is also tempting. So what's my problem? The post Should I ignore the falling GlaxoSmithKline share price and pocket its 6% yield anyway? appeared first on The Motley Fool UK.
- Zacks
Glaxo (GSK) Gets FDA Nod for Long-Acting HIV Regimen Cabenuva
Glaxo (GSK) and J&J's (JNJ)get FDA approval for Cabenuva, a once-monthly injectable regimen of cabotegravir and rilpivirine, for the treatment of adults with virally suppressed HIV-1 infection.
- Zacks
Pharma Stock Roundup: FDA Nod to MRK, AZN, JNJ, GSK Drugs, LLY's New Antibody Deal
Merck (MRK), Glaxo (GSK), AstraZeneca (AZN) and J&J (JNJ) announce FDA approvals.
© 2021 Verizon Media. All rights reserved.
